Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bleakley Financial Group Chooses PKS Investments, a Subsidiary of Binah Capital Group, as Broker-Dealer for Hybrid Advisory Services
-
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
-
Sweet Innovation, Less Sugar: Chanson International Holding Refines Natural Sweetener Blend for Healthier Beverages and Baked Goods
-
Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress
-
Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results
-
Gaxos Labs Approved for Listing on Amazon Web Services (AWS) Marketplace
-
Respect Together Honors 50 Years of Impact and Charts a New Era for Survivors
-
GoHealth’s Statement on Recent Allegations in the United States False Claims Act Complaint
-
Hecate Grid Announces Rebrand to Fullmark Energy, Marking New Era of Energy Storage Leadership
-
GCM Grosvenor Reports First Quarter 2025 Earnings Results, with Quarter-To-Date Fundraising Increasing 77% Year-Over-Year, Quarter-to-Date GAAP Net Income of $0.5 million, and Fee-Related Earnings and
-
Households with Children Emerge as Power Users of the Gig Economy
-
JFB Construction Holdings Awarded $18 Million Contract as General Contractor for Co-Developed New Courtyard by Marriott in Olive Branch, MS
-
PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results
-
Super League Announces Cost Structure Reductions Amid Drive Towards Profitability
-
ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilo
-
Legends Global Partners Launches New Real Estate Investment and Development Venture
-
BitFuFu Announces Sponsorship and Featured Speaker Appearance at Bitcoin 2025
-
New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress
-
Arax Recognizes Partner Firms Named on USA Today’s List of Best Financial Advisory Firms 2025
-
Ashton Thomas Private Wealth Ranked #7 on USA Today’s List of Best Financial Advisory Firms 2025
-
GlobalTech and Talina AI Initiate Collaboration to Innovate AI-Driven Global Talent Acquisition
-
Otto Aviation CEO Paul Touw to Serve as Keynote Speaker at the 4th Annual Sustainable Skies World Summit
-
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
-
Future Today Takes Center Stage at IAB NewFronts 2025
-
Intermex Reports First-Quarter Results
-
Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025
-
Bamboo Insurance Enhances Customer Experience and Reduces Costs with ManageMy Digital Document Delivery Platform
-
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
-
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology
-
Counslr Partners with Sack the Stigma to Expand Mental Health Wellness Resources
-
Procedure for the Payment of AB Kauno Energija Dividends for 2024
-
Pyxis Tankers Announces Loan Commitment for Potential Fleet Expansion
-
Testsigma announces autonomous testing capabilities - ushering in the era of agentic AI
-
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
-
Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher
-
ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1 Agonists to Address Unmet Medical Needs of People Living with Obesity; Provides R&D Update
-
ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1 Agonists to Address Unmet Medical Needs of People Living with Obesity; Provides R&D Update
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
XYZ Media’s “Next Generation of Innovators” Series Spotlights Aidan Cao for His Pinecone-Inspired Hygrobots for Biomedical Applications
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - LONDONMETRIC PROPERTY PLC - Ordinary Shares
-
Momcozy Launches SniffEase Baby Nasal Aspirator with Hospital-Grade Suction for Gentle and Effective Congestion Relief
-
Blockchain network “Make in Vietnam”: Master strategic infrastructure technology
-
Costamare Inc. Announces Completion of the Costamare Bulkers Holdings Limited Spin-Off
-
Costamare Bulkers Holdings Limited Debuts as Independent, Publicly Traded Company
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Sunrise Realty Trust, Inc. Announces Financial Results for the First Quarter 2025
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares
-
Abaxx Announces First Carbon Futures Delivery on Abaxx Exchange
-
Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update
